Dupuytren Contracture Clinical Trial
Official title:
The Effects of Prophylactic Limited Palmar Fasciectomy on Surgical Outcomes and Scarring for Dupuytren's Contracture Patients With Pretendinous Cord - Prospective Randomized Clinical Study (Pilot)
NCT number | NCT03155854 |
Other study ID # | 15-008280 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | September 2016 |
Est. completion date | December 2024 |
Verified date | April 2024 |
Source | Mayo Clinic |
Contact | Sanjeev Kakar, MD |
Kakar.Sanjeev[@]mayo.edu | |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Research is instrumental for improving medical care and the patient experience. Finding new surgical techniques can create better outcomes and minimize recovery time and complications for patients. Some patients undergoing trigger finger surgery with a pre-existing Dupuytren's cord may develop a thickened surgical scar after surgery, which can cause discomfort, difficulty with moving or using, and other complications in the affected finger(s) or hand. The investigator is investigating a surgical technique to minimize these potential complications and scarring after surgery. Subjects are being asked to take part in this research study because they have been diagnosed with trigger finger and pretendinous Dupuytren's cord and have decided to undergo surgery rather than try medical treatment.
Status | Recruiting |
Enrollment | 50 |
Est. completion date | December 2024 |
Est. primary completion date | December 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Potential candidates for the study will be selected based upon clinical diagnosis of trigger finger with co-existing pretendinous cord. All potential subjects will have either failed non operative treatment or elected surgical treatment. Exclusion Criteria: - <18 years of age |
Country | Name | City | State |
---|---|---|---|
United States | Mayo Clinic | Rochester | Minnesota |
Lead Sponsor | Collaborator |
---|---|
Mayo Clinic |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Scar Progression as measured by the Vancouver Scar Scale | The Vancouver Scar Scale assesses 4 variables: vascularity, height/thickness, pliability, and pigmentation. Patient perception of his or her respective scars is not factored in to the overall score. The scores can range from 0 (normal) to 13 (severe scarring). | baseline, up to 1 year | |
Primary | Change in Scar Progression as measured by the Patient and Observer Scar Assessment Scale | The Patient and Observer Scar Assessment Scale consists of two parts: a Patient Scale and an Observer Scale. Both scales contain seven items that are scored numerically on a 10-step scale. Together they make up the 'Total Score' of the Patient and Observer Scale. The total score can range from 14 (normal) to 140 (worst scar imaginable). | baseline, up to 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03192020 -
Trial Comparing Treatment Strategies in Dupuytren's Contracture
|
Phase 4 | |
Recruiting |
NCT05300893 -
Effectiveness of Night Splinting After Percutaneous Needle Fasciotomy in Dupuytren's Contracture
|
N/A | |
Completed |
NCT02647619 -
Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF
|
Phase 4 | |
Recruiting |
NCT01184586 -
Dupuytren's Disease and Extracorporeal Shockwave Therapy (DupuyShock-2010)
|
Phase 2 | |
Recruiting |
NCT04122313 -
Post-contracture Release Radiation for Dupuytren's Disease
|
||
Withdrawn |
NCT01776892 -
Collagenase and Needle Aponeurotomy: Single Modality Versus Combination Treatment for Dupuytren's Disease
|
Phase 3 | |
Completed |
NCT02983162 -
Is wGRS Associated With DD Recurrence?
|
||
Completed |
NCT01923103 -
Natural Disease Progress of Dupuytren Disease
|
||
Enrolling by invitation |
NCT03982719 -
Comparing the Effectiveness of Two Post-fasciectomy Rehabilitation Protocols in Patients With Dupuytren's Disease
|
N/A | |
Not yet recruiting |
NCT04907812 -
The Role of Tranexamic Acid in Reducing Post Operative Hand Edema After Hand and Wrist Surgery
|
Phase 4 | |
Withdrawn |
NCT03031080 -
BOND Study: the Benefit Of Night Splinting in Dupuytrens'
|
N/A | |
Completed |
NCT04874870 -
Effectiveness of Splinting After Collagenase Injection
|
Phase 3 | |
Active, not recruiting |
NCT03407820 -
Different Sutures in Hand Surgery
|
N/A | |
Recruiting |
NCT03000114 -
Collagenase Injection vs Percutaneous Needle Aponeurotomy for Dupuytren's Disease
|
Phase 4 | |
Recruiting |
NCT05440240 -
Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture
|
Phase 4 | |
Completed |
NCT03331926 -
Collagenase is a Common Treatment of MCP and PIP Joint Contractures in Dupuytrens Disease
|
||
Active, not recruiting |
NCT03741764 -
Treatment of Dupuytren's Disease With Minimal Invasive Surgery and VIVOSORB® Resorbable Implant Device
|
N/A | |
Completed |
NCT01876498 -
Registry of Patient With M. Dupuytren and Validation of the Brief MHQ
|
N/A | |
Completed |
NCT03868449 -
Question Prompt List for Common Hand Conditions
|
N/A | |
Completed |
NCT03573765 -
Epidemiology and Outcomes of Upper Limb Surgery: Analysis of Routine Data
|